Phase 3 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 years old
- People whose PSA blood test result is below 10 ng/mL before surgery
- People whose prostate cancer has been graded as ISUP grade 2 or lower, and has not spread beyond the prostate (stage cT2 or lower), based on a biopsy
- People who are having a type of keyhole robotic prostate removal surgery where the surgeon takes care to preserve the nerves around the prostate
- People whose score on a sexual function questionnaire (called the IIEF-5) is 17 or higher before surgery
- People whose first PSA blood test result after surgery (taken around 45 days later) is below 0.1
- People whose final tissue results after surgery confirm the cancer is ISUP grade 2 or lower and has not spread to a certain extent (pT stage below 3b)
- People who are willing and able to follow the study requirements, including completing questionnaires about sexual function and quality of life
- People who are able to provide written consent to take part in the trial
Who may not be able to join:
- People for whom robotic surgery is not safe due to anaesthesia-related health concerns
- People who have previously had radiotherapy to the pelvis or hormone treatment to lower testosterone (androgen deprivation therapy)
- People who experience serious complications after surgery (graded as Clavien-Dindo grade 3 or higher — confirm with trial site)
- People for whom a group of medications used to treat erectile difficulties (called PDE5 inhibitors) would not be safe due to heart or blood vessel health concerns
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0652665005
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Erectile Function
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.